Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

The demand for advanced diabetes care goods, including insulin pumps, pens, and continuous glucose ... with Abbott’s FreeStyle Libre 2+ and Dexcom’s G6 CGM sensors, expanding its reach.

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Nearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.

Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...